At the time the deal was announced, Idenix was PBE’s ninth-lagest holding with a weight of 3%. The ETF enters Monday with 3.48% allocation to InterMune, enough to make the stock the fund’s tenth-largest holding. [Why These Biotech ETFs are Surging]

InterMune occupies weights of 1.54% and 1.16%, respectively, in the SPDR S&P Biotech ETF (NYSEArca: XBI) and the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB). IBB is the largest biotech ETF with almost $5.3 billion in assets.

First Trust NYSE Arca Biotechnology Index Fund

ETF Trends editorial team contributed to this post.

Subscribe to our free daily newsletters!
Please enter your email address to subscribe to ETF Trends' newsletters featuring latest news and educational events.